Developing a diagnostic model for predicting prostate cancer: a retrospective study based on Chinese multicenter clinical data

Cancer statistics, 2023

(2023) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention

(2023) Tyler M. Seibert et al.   EUROPEAN UROLOGY

Development of a nomogram combining multiparametric magnetic resonance imaging and PSA‐related parameters to enhance the detection of clinically significant cancer across different region

(2022) Zhien Zhou et al.   PROSTATE

Construction and Validation of a Clinical Predictive Nomogram for Improving the Cancer Detection of Prostate Naive Biopsy Based on Chinese Multicenter Clinical Data

(2022) Tao Tao et al.   Frontiers in Oncology

Low-Grade Prostate Cancer: Time to Stop Calling It Cancer

(2022) Scott E. Eggener et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score

(2022) Max Peters et al.   EUROPEAN UROLOGY

New model of PIRADS and adjusted prostatespecific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study

(2022) Yu-Hua Huang et al.   ASIAN JOURNAL OF ANDROLOGY

Prostate cancer treatment – China's perspective

(2022) Jiazhou Liu et al.   CANCER LETTERS

CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer

(2022) Tommy Nyberg et al.   JOURNAL OF CLINICAL ONCOLOGY

11 clinical trials that will shape medicine in 2023

(2022) Carrie Arnold et al.   NATURE MEDICINE

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

(2022) Jonas Hugosson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reducing Prostate Cancer Overdiagnosis

(2022) Roman Gulati   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology and genomics of prostate cancer in Asian men

(2021) Yao Zhu et al.   Nature Reviews Urology

Liquid biomarkers in active surveillance

(2021) Marc Dall’Era   WORLD JOURNAL OF UROLOGY

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

(2021) Hendrik Van Poppel et al.   EUROPEAN UROLOGY

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

(2021) Tobias Nordström et al.   LANCET ONCOLOGY

A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2–10 ng/mL at initial biopsy

(2021) Ya-Di He et al.   Molecular Cancer

Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection

(2021) Thomas A. Hope et al.   JAMA Oncology

Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml-1 in Western China

(2021) Qian Niu et al.   ASIAN JOURNAL OF ANDROLOGY

Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography

(2021) Valentin H. Meissner et al.   EUROPEAN UROLOGY

Inherited Mutations in Chinese Men With Prostate Cancer

(2021) Yao Zhu et al.   Journal of the National Comprehensive Cancer Network

Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study

(2020) Brendan Berry et al.   BJU INTERNATIONAL

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

(2020) Michael Ahdoot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

(2020) Michael S Hofman et al.   LANCET

A genomic and epigenomic atlas of prostate cancer in Asian populations

(2020) Jing Li et al.   NATURE

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2020) C. Parker et al.   ANNALS OF ONCOLOGY

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

(2020) Nicolas Mottet et al.   EUROPEAN UROLOGY

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2

(2019) Baris Turkbey et al.   EUROPEAN UROLOGY

A Novel Prediction Tool Based on Multiparametric Magnetic Resonance Imaging to Determine the Biopsy Strategy for Clinically Significant Prostate Cancer in Patients with PSA Levels Less than 50 ng/ml

(2019) Bi-Ming He et al.   ANNALS OF SURGICAL ONCOLOGY

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

(2018) Claudia Allemani et al.   LANCET

A Magnetic Resonance Imaging–Based Prediction Model for Prostate Biopsy Risk Stratification

(2018) Sherif Mehralivand et al.   JAMA Oncology

Correlating blood-based DNA methylation markers and prostate cancer risk in African-American men

(2018) Emmanuel Moses-Fynn et al.   PLoS One

Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts

(2017) Rui Chen et al.   JOURNAL OF UROLOGY

Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies

(2016) Leander Van Neste et al.   PROSTATE

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

(2015) Jonathan I. Epstein et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary Europe

(2015) Cédric Poyet et al.   BJU INTERNATIONAL

Nomograms in oncology: more than meets the eye

(2015) Vinod P Balachandran et al.   LANCET ONCOLOGY

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

(2015) Henrik Grönberg et al.   LANCET ONCOLOGY

Expressed Prostatic Secretion Biomarkers Improve Stratification of NCCN Active Surveillance Candidates: Performance of Secretion Capacity and TMPRSS2:ERG Models

(2013) Christopher Whelan et al.   JOURNAL OF UROLOGY

External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort

(2012) Yao Zhu et al.   ASIAN JOURNAL OF ANDROLOGY